Cell-free utDNA may predict transurethral resection of bladder tumour pathology in NMIBC скачать в хорошем качестве

Cell-free utDNA may predict transurethral resection of bladder tumour pathology in NMIBC

Dr Kyle Rose speaks to ecancer at ASCO GU 2023 about his talk on a prospective study that used cell-free urinary tumour DNA to detect minimal residual disease prior to repeat-transurethral resection of bladder tumours in non–muscle-invasive bladder cancer. He explains that cell-free urinary tumour DNA generated from tumour genomic sequencing is an emerging biomarker showing tremendous potential for detecting minimal residual disease in muscle-invasive and metastatic bladder cancer. The results showed that urinary tumour DNA demonstrates promise as a surrogate for minimal residual disease and may predict transurethral resection of bladder tumour pathology for non–muscle-invasive bladder cancer. Sign up to ecancer for free to receive tailored email alerts for more videos like this. ecancer.org/account/register.php